| 0.2 |
0.5 |
GO:1990709 |
maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
| 0.1 |
0.4 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 |
0.1 |
GO:0051783 |
regulation of nuclear division(GO:0051783) |
| 0.1 |
0.4 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.1 |
0.6 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.2 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.2 |
GO:0060127 |
subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.0 |
0.0 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.0 |
0.2 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.0 |
0.2 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.1 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.0 |
0.2 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.0 |
0.1 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.0 |
0.3 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.1 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.1 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.0 |
0.4 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.0 |
0.2 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.3 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
0.0 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.1 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.0 |
0.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.0 |
0.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.2 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.1 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.0 |
0.1 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.2 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.3 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.2 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.0 |
GO:0003094 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 |
0.2 |
GO:0072331 |
signal transduction by p53 class mediator(GO:0072331) |
| 0.0 |
0.1 |
GO:0001897 |
cytolysis by symbiont of host cells(GO:0001897) |
| 0.0 |
0.1 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 |
0.1 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.0 |
0.0 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 |
0.1 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.0 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
0.1 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.0 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.0 |
0.1 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:1990641 |
cellular response to bile acid(GO:1903413) response to iron ion starvation(GO:1990641) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.0 |
0.1 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.0 |
0.2 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.2 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.0 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.1 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.0 |
0.0 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.0 |
0.2 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 |
0.0 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 |
0.0 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.0 |
0.2 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 |
0.1 |
GO:0002877 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.0 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.0 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.0 |
0.1 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.0 |
0.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.0 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.1 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.0 |
0.1 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.2 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
0.0 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.0 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.0 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.0 |
0.2 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.0 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.0 |
0.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.0 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.0 |
0.3 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.0 |
0.0 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.0 |
0.4 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
0.5 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.0 |
0.1 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.0 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.0 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.0 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.0 |
0.3 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.0 |
GO:1902990 |
leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 |
0.0 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.0 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.0 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.0 |
0.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.0 |
0.0 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 |
0.1 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.1 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.0 |
0.0 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.0 |
0.1 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 |
0.0 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.1 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
